BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
| Q1 2023 | $50,700 | -0.6% | 1,250 | +25.0% | 0.00% | 0.0% |
| Q4 2022 | $51,000 | -5.6% | 1,000 | 0.0% | 0.00% | -50.0% |
| Q3 2022 | $54,000 | -89.5% | 1,000 | -87.5% | 0.00% | -84.6% |
| Q2 2022 | $515,000 | -36.5% | 8,014 | -23.4% | 0.01% | -23.5% |
| Q1 2022 | $811,000 | -9.8% | 10,464 | 0.0% | 0.02% | -5.6% |
| Q4 2021 | $899,000 | +27.2% | 10,464 | +18.7% | 0.02% | +20.0% |
| Q3 2021 | $707,000 | -31.2% | 8,814 | -30.9% | 0.02% | -34.8% |
| Q2 2021 | $1,027,000 | +75.0% | 12,755 | +83.2% | 0.02% | +76.9% |
| Q1 2021 | $587,000 | – | 6,964 | – | 0.01% | – |
| Q4 2020 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
| Q3 2020 | $424,000 | -19.2% | 5,270 | -13.6% | 0.01% | -27.8% |
| Q2 2020 | $525,000 | +6.5% | 6,100 | +0.6% | 0.02% | -14.3% |
| Q1 2020 | $493,000 | +508.6% | 6,064 | +529.0% | 0.02% | +600.0% |
| Q4 2019 | $81,000 | -3.6% | 964 | 0.0% | 0.00% | -25.0% |
| Q3 2019 | $84,000 | +6.3% | 964 | 0.0% | 0.00% | +33.3% |
| Q2 2019 | $79,000 | +1.3% | 964 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $78,000 | +23.8% | 964 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $63,000 | -4.5% | 964 | -5.4% | 0.00% | +50.0% |
| Q1 2018 | $66,000 | -64.1% | 1,019 | -64.3% | 0.00% | -33.3% |
| Q4 2017 | $184,000 | +174.6% | 2,856 | +159.6% | 0.00% | +50.0% |
| Q2 2017 | $67,000 | +17.5% | 1,100 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $57,000 | +280.0% | 1,100 | +235.4% | 0.00% | – |
| Q4 2016 | $15,000 | -6.2% | 328 | 0.0% | 0.00% | – |
| Q3 2016 | $16,000 | +6.7% | 328 | 0.0% | 0.00% | – |
| Q2 2016 | $15,000 | -81.2% | 328 | -83.1% | 0.00% | -100.0% |
| Q1 2016 | $80,000 | +8.1% | 1,942 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $74,000 | +174.1% | 1,942 | +131.2% | 0.00% | +100.0% |
| Q3 2015 | $27,000 | -91.9% | 840 | -82.3% | 0.00% | -91.7% |
| Q2 2015 | $332,000 | -40.6% | 4,740 | -41.9% | 0.01% | -42.9% |
| Q1 2015 | $559,000 | -4.1% | 8,158 | +2.5% | 0.02% | -22.2% |
| Q4 2014 | $583,000 | -65.0% | 7,958 | -65.7% | 0.03% | -59.7% |
| Q3 2014 | $1,664,000 | -6.6% | 23,183 | -6.0% | 0.07% | -5.6% |
| Q2 2014 | $1,782,000 | -19.7% | 24,657 | -18.2% | 0.07% | -22.8% |
| Q1 2014 | $2,220,000 | +23.2% | 30,154 | +16.3% | 0.09% | +21.1% |
| Q4 2013 | $1,802,000 | – | 25,918 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |